RxDoctor Payments Data

Stephane Rinfret

Interventional Cardiology · Gainesville, GANPI 1679168470

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.6%. Reporting peaked in 2023 at $30,333 and has fallen 91.5% since, to $2,565 in 2025.

$71,713in general payments, 2019–2025

Across 251 payments — averaging $285.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$17K
  • Arrow International, Inc.$15K
  • Medtronic$13K
  • Abiomed$13K
  • Boston Scientific$7K
  • Shockwave Medical, Inc$2K
  • plus $5K from 16 others

What the payments were for

  • Consulting fees$24,75035%
  • Speaking & faculty fees$24,31834%
  • Travel & lodging$7,87411%
  • Food & beverage$14,77121%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,713 in reported general payments places this provider in the 85th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Medicare billing

Part B allowed, 2024
$101,295
Medicare patients
436
Services billed
902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor18$10,374
Prasugrel Hcl13$344
ClopidogrelClopidogrel Bisulfate32$343
Isosorbide Mononitrate ErIsosorbide Mononitrate11$55

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →